88
Views
1
CrossRef citations to date
0
Altmetric
Review

Assessment of medication therapy adherence in glaucoma: scoping review

ORCID Icon, &
Pages 113-124 | Received 21 Jul 2020, Accepted 22 Oct 2020, Published online: 05 Nov 2020

References

  • Malvankar-Mehta MS, Feng L, Hutnik CML. <p>North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. Clin Outcomes Res. 2019;11:789–798.
  • Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology [Internet]. 2014;121(11):2081–2090.
  • SNS. Estratégia Nacional para a Saúde da Visão. Report No.: DR no35/18. Portugal; 2018. (II).
  • Stelmack J, Stelmack T, Massof R. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Investig Ophthalmol Vis Sci. 2002;43(9):2859–2868.
  • Lui MH, Lam JCH, Kwong YL, et al. A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population. Int J Ophthalmol. 2017;10(2):293–299.
  • WHO Working Group. The global initiative for the elimination of avoidable blindness - vision 2020: the right to sight. Comm Eye health/Int Centre Eye Health. 1992 Mar;12(30):32.
  • Vélez-Gómez MC, Vásquez-Trespalacios EM. Adherencia al tratamiento tópico del glaucoma, factores protectores y de riesgo; una revisión del tema. Arch Soc Esp Oftalmol [Internet]. 2017;93(2):87–92.
  • Mapa Terapêutico [Internet]. [cited 2019 Oct 21]. Available from: https://mapaterapeutico.pt/atc-infarmed/s01e-farmacos-anti-glaucoma-e-mioticos
  • Castro A, Mesquita W. Não-adesão à terapêutica medicamentosa do glaucoma. Arq Bras Oftalmol. 2008;71(2):207–214.
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.
  • Coelho A, Vilares C, Silva M, et al. Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito. Rev Port Med Geral Fam. 2017 Aug;262–276.
  • Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence. 2008;2:303–313.
  • Picanço A. Avaliação da Iniciação, Implementação e Persistência no Tratamento na Diabetes Mellitus tipo 2 na região de saúde de Lisboa e Vale do Tejo [Dissertation]. Lisboa: Escola Superior de Tecnologia da Saúde de Lisboa/Instituto Politécnico de Lisboa; 2016.
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32.
  • Newman-Casey PA, Killeen OJ, Renner M, et al. Access to and experiences with, e-health technology among glaucoma patients and their relationship with medication adherence. Telemed e-Health. 2018;24(12):1026–1035.
  • Yousuf SJ, Jones LS. Adherence to topical glaucoma medication during hospitalization. J Glaucoma. 2011;20(9):573–576.
  • Newman-Casey PA, Blachley T, Lee PP, et al. Patterns of glaucoma medication adherence over four years of follow-Up. Ophthalmology. 2015;122(10):2010–2021.
  • Reardon G, Schwartz GF, Kotak S. Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy. BMC Ophthalmol. 2010;10(5). DOI:10.1186/1471-2415-10-5.
  • Traverso CE, Walt JG, Stern LS, et al. Pharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucoma. J Ocul Pharmacol Ther. 2009;25(1):77–82.
  • Hahn SR, Kotak S, Tan J, et al. Physicians treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma. Curr Med Res Opin. 2010;26(4):957–963.
  • Sheer R, Bunniran S, Uribe C, et al. Predictors of nonadherence to topical intraocular pressure reduction medications among medicare members: A claims-based retrospective cohort study. J Manag Care Spec Pharm. 2016;22(7):808–817.
  • Kumar JB, Bosworth HB, Sleath B, et al. Quantifying glaucoma medication adherence: the relationship between self-report, electronic monitoring, and pharmacy refill. J Ocul Pharmacol Ther. 2016;32(6):346–354.
  • Sleath B, Carpenter DM, Blalock SJ, et al. Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence. Health Educ Res. 2015;30(5):693–705.
  • Stringham J, Ashkenazy N, Galor A, et al. Barriers to glaucoma medication compliance among veterans: dry eye symptoms and anxiety disorders. Eye Contact Lens. 2018;44(1):50–54.
  • Jones JP, Fong DS, Fang EN, et al. Characterization of glaucoma medication adherence in Kaiser permanente Southern California. J Glaucoma. 2016;25(1):22–26.
  • Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2012;21(4):234–240.
  • Asefzadeh B, Rett D, Pogoda TK, et al. Glaucoma medication adherence in veterans and influence of coexisting chronic disease. J Glaucoma. 2014;23(4):240–245.
  • Ung C, Zhang E, Alfaro T, et al. Glaucoma severity and medication adherence in a County Hospital Population. Ophthalmology. 2013;120(6):1150–1157.
  • Newman-Casey PA, Robin AL, Blachley T, et al. Most common barriers to glaucoma medication adherence: A cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316.
  • Sleath B, Hill C, Blalock SJ, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2015;122(4):748–754.
  • Djafari F, Lesk MR, Harasymowycz PJ, et al. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18(3):238–242.
  • Kholdebarin R, Campbell RJ, Jin Y. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454–461.
  • Leung VC, Jin YP, Hatch W, et al. The relationship between sociodemographic factors and persistence with topical glaucoma medications. J Glaucoma. 2015;24(1):69–76.
  • Mowatt L, Nelson-Imoru J, Gordon-Strachan G. Glaucoma medication compliance issues in a Jamaican Hospital Eye Clinic. West Indian Med J. 2011;60(5):541–547.
  • Amaral A, Leitão P, Silva J, et al. Monitorização da Adesão à Terapêutica Médica do Glaucoma. Oftalmologia. 2009;33:101–107.
  • Hermann MM, Bron AM, Creuzot-Garcher CP, et al. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. J Glaucoma. 2011;20(8):502–508.
  • Mansouri K, Iliev ME, Rohrer K, et al. Compliance and knowledge about glaucoma in patients at tertiary glaucoma units. Int Ophthalmol. 2011;31(5):369–376.
  • Lunnela J, Kääriäinen M, Kyngäs H. Adherence of Finnish people with glaucoma to treatment plans and connected factors. Int J Circumpolar Health. 2011;70(1):79–89.
  • Tse AP, Shah M, Jamal N, et al. Glaucoma treatment adherence at a United Kingdom general practice. Eye [Internet]. 2016;30(8):1118–1122.
  • Thompson AC, Woolson S, Olsen MK, et al. Relationship between electronically measured medication adherence and vision-related quality of life in a cohort of patients with open-angle glaucoma. BMJ Open Ophthalmol. 2018;3(1):1–7.
  • Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of factors affecting patients’ compliance to topical antiglaucoma medications in Egypt as a developing country model. J Ophthalmol. 2015;2015:1–7.
  • Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol [Internet]. 2015;15111:1–8.
  • Tamrat L, Gessesse GW, Gelaw Y. Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015;22(1):59–63.
  • Quek DTL, Ong GT, Perera SA, et al. Persistence of patients receiving topical glaucoma monotherapy in an Asian population. Arch Ophthalmol. 2011;129(5):643–648.
  • Park MH, Kang KD, Moon J. Noncompliance with glaucoma medication in Korean patients: A multicenter qualitative study. Jpn J Ophthalmol. 2012;57(1):47–56.
  • Kim CY, Park KH, Ahn J, et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017;101:801–807.
  • Rajurkar K, Dubey S, Gupta PP, et al. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol [Internet]. 2018;30(2):125–129.
  • Weiss GA, Goldich Y, Bartov E, et al. Compliance with eye care in glaucoma patients with comorbid depression. Isr Med Assoc J. 2011;13(12):730–733.
  • McClelland J, Bodle L, Little J-A. Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes. Patient Prefer Adherence. 2019;13:431–439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.